OJ-057 Trends for Risk Factors and Cardiovascular Disease in a Rural Community in Japan from 1963 to 2002(Preventive medicine/Epidemiology/Education-2 (H) OJ10,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Cir

スポンサーリンク

概要

著者

関連論文

Pravastatin Use and the Five-year Incidence of Cancer in Coronary Heart Disease Patients : from the Prevention of Coronary Sclerosis Study
Evaluation of Coronary Artery Calcification by Multi-detector Row Computed Tomography for the Detection of Coronary Artery Stenosis in Japanese Patients
Establishment of Long-Term Monitoring System for Blood Chemistry Data by the National Health and Nutrition Survey in Japan
Body Fat Distribution and the Risk of Hypertension and Diabetes among Japanese Men and Women
Associations of Sleep-Disordered Breathing with Excessive Daytime Sleepiness and Blood Pressure in Japanese Women
Establishment of External Quality Control Program for hs-CRP and Three-Year Follow-Up of the Performance for Precision and Accuracy
PE-249 Trial for the Frequency of Brugada-type ECG in Population(ECG/Body surface potential mapping/Holter-5 (A) PE42,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
Relationship between Sleep-Disordered Breathing and Blood Pressure Levels in Community-Based Samples of Japanese Men
Smoking Raises the Risk of Total and Ischemic Strokes in Hypertensive Men
A Case-Reference Study on Plasma Fibrinogen Concentrations and Coronary Atherosclerosis in Japanese
High Sensitive C-Reacting Protein, Fibrinogen, White Blood Cell and the Recurrences of Cardiovascular Diseases on Five-Year Follow-Up of PCS Study
Was the Extremely High Level of Serum HDL Cholesterol Concentration a Risk for Cardiovascular Diseases?(Cardiovascular Preventive Medicine (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Standardization of Laboratory Test in the JPHC Study
Standardization of Laboratory Test in the JPHC Study
Cost -effectiveness analysis for secondary prevention from coronary heart disease using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to normocholesterolemic patients
Impact of Pravastatin on secondary prevention of coronary artery disease in normolipidemic patients : 5-Year Follow-up Results of PCS study
OJ-057 Trends for Risk Factors and Cardiovascular Disease in a Rural Community in Japan from 1963 to 2002(Preventive medicine/Epidemiology/Education-2 (H) OJ10,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Cir

もっと見る

スポンサーリンク